{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:11:10Z","timestamp":1773799870284,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>\n            The severe acute respiratory syndrome coronavirus 2 is known to infect host cells by interacting with ACE2 (angiotensin-converting enzyme 2) expressed in the respiratory epithelium. There have been concerns on whether alterations of ACE2 expression by renin-angiotensin-aldosterone system (RAAS) inhibitors would contribute to the infectivity and severity of coronavirus disease 2019 (COVID-19). We performed a case-control study to investigate the association between RAAS inhibitors and risk and severity of COVID-19 infection in South Korea using the population-based data provided by the Korean National Health Insurance System. Of 16 281 subjects with hypertension, there were 950 (5.8%) confirmed COVID-19 cases. After case-control matching, multivariable-adjusted conditional logistic regression analysis was performed. The adjusted odds ratio and 95% CIs for COVID-19 infection and long-term hospitalization comparing exposure to RAAS inhibitors and nonexposure to RAAS inhibitors was 1.161 (0.958\u20131.407) and 0.863 (0.533\u20131.397), respectively. When comparing exposure to RAAS inhibitors and nonexposure to RAAS inhibitors for intensive care unit admission, high-flow oxygen therapy, and death, the adjusted odds ratios (95% CIs) were 1.515 (0.402\u20135.701), 0.663 (0.272\u20131.619), and 1.363 (0.513\u20133.662), respectively. In all analyses,\n            <jats:italic>P<\/jats:italic>\n            values were not significant (\n            <jats:italic>P<\/jats:italic>\n            &gt;0.05). The present study demonstrates the absence of an identifiable association between the exposure to RAAS inhibitors and risk and severity of COVID-19 infection, supporting the current medical guidelines and recommendations that patients should not discontinue RAAS inhibitors out of a concern that they are at increased risk for infection or severe illness of COVID-19.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.15464","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:00:49Z","timestamp":1594630849000},"page":"742-749","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea"],"prefix":"10.1161","volume":"76","author":[{"given":"Minkook","family":"Son","sequence":"first","affiliation":[{"name":"From the Department of Biomedical Science and Engineering (M.S., S.Y.), Gwangju Institute of Science and Technology, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeongkuk","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Armed Forces Goyang Hospital, Goyang-si, Republic of Korea (J.S.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-0993","authenticated-orcid":true,"given":"Sung","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Department of Biomedical Science and Engineering (M.S., S.Y.), Gwangju Institute of Science and Technology, Republic of Korea"},{"name":"School of Mechanical Engineering (S.Y.), Gwangju Institute of Science and Technology, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","unstructured":"WHO. Coronavirus Disease (COVID-19) Situation Report \u2013 106. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\/. 2020. Accessed May 5 2020."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.04.001"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15082"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa235"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"e_1_3_4_14_2","unstructured":"KCDC. The updates on COVID-19 in Korea as of May 3. http:\/\/ncov.mohw.go.kr\/en\/. Korea Centers of Disease Control and Prevention. 2020. Accessed May 3 2020."},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.031"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0802"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050755"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2020.40.5.351"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0534-7"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2009575"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05967-x"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007723"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.025536"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17041244"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e1"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(02)00585-1"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.20526"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30085-2"},{"key":"e_1_3_4_32_2","unstructured":"Washington Post. Coronavirus death toll: Americans are almost certainly dying of covid-19 but being left out of the official count. https:\/\/www.washingtonpost.com\/investigations\/coronavirus-death-toll-americans-are-almost-certainly-dying-of-covid-19-but-being-left-out-of-the-official-count\/2020\/04\/05\/71d67982-747e-11ea-87da-77a8136c1a6d_story.html. Accessed April 6 2020."},{"key":"e_1_3_4_33_2","first-page":"177","article-title":"Predicting the mortality due to Covid-19 by the next month for Italy, Iran and South Korea; a simulation study.","volume":"13","author":"Shojaee S","year":"2020","unstructured":"Shojaee, S, Pourhoseingholi, MA, Ashtari, S, Vahedian-Azimi, A, Asadzadeh-Aghdaei, H, Zali, MR. Predicting the mortality due to Covid-19 by the next month for Italy, Iran and South Korea; a simulation study. Gastroenterol Hepatol Bed Bench. 2020;13:177\u2013179.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaa082"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-018-0098-0"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.15464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:45:51Z","timestamp":1715597151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.15464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.15464"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.15464","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}